Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia with Pegasparaginase and Erwinia Asparaginase: The Impact of Expensive Chemotherapy

被引：0
|
作者：
Tong, Wing H. [1 ]
van der Sluis, Inge M. [1 ]
Alleman, Cathelijne [2 ]
van Litsenburg, Raphaele R. L. [3 ]
Kaspers, Gertjan [3 ]
Pieters, Rob [1 ]
Uyl-de Groot, Carin A. [2 ]
机构：
[1] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands
[2] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4227.4227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4227
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
    Tong, Wing H.
    van der Sluis, Inge M.
    Alleman, Cathelijne J. M.
    van Litsenburg, Raphaele R. L.
    Kaspers, Gertjan J. L.
    Pieters, Rob
    Uyl-de Groot, Carin A.
    HAEMATOLOGICA, 2013, 98 (05) : 753 - 759
  • [2] A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia
    Kloos, Robin Q. H.
    van Litsenburg, Raphaele R. L.
    Wolf, Sarah
    Wismans, Leonoor
    Kaspers, Gertjan J. L.
    Uyl-de Groot, Carin A.
    Pieters, Rob
    van der Sluis, Inge M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (01)
  • [3] A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
    Tong, Wing H.
    Pieters, Rob
    Kaspers, Gertjan J. L.
    te Loo, D. Maroeska W. M.
    Bierings, Marc B.
    van den Bos, Cor
    Kollen, Wouter J. W.
    Hop, Wim C. J.
    Lanvers-Kaminsky, Claudia
    Relling, Mary V.
    Tissing, Wim J. E.
    van der Sluis, Inge M.
    BLOOD, 2014, 123 (13) : 2026 - 2033
  • [4] Cost-Effectiveness of Treatment of Childhood Acute Lymphoblastic Leukemia With Chemotherapy Only: The Influence of New Medication and Diagnostic Technology
    van Litsenburg, Raphaele R. L.
    Uyl-de Groot, Carin A.
    Raat, Hein
    Kaspers, Gertjan J. L.
    Gemke, Reinoud J. B. J.
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1005 - 1010
  • [5] Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia
    Salzer, Wanda L.
    Asselin, Barbara L.
    Plourde, Paul V.
    Corn, Tim
    Hunger, Stephen P.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013, 2014, 1329 : 81 - 92
  • [6] Erwinia asparaginase in pediatric acute lymphoblastic leukemia
    Salzer, Wanda
    Seibel, Nita
    Smith, Malcolm
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1407 - 1414
  • [7] Asparaginase Erwinia chrysanthemi-rywn for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma
    Gao, Congying
    Ma, Xiangyu
    Zhang, Zifan
    Lu, Qisi
    Ashby, Charles R.
    Wei, Liuya
    Chen, Zhe-Sheng
    DRUGS OF TODAY, 2022, 58 (06) : 261 - 271
  • [8] Thyroid function is not affected by second exposure to Erwinia asparaginase for childhood acute lymphoblastic leukemia
    Bossi, G
    Larizza, D
    Conter, V
    HAEMATOLOGICA, 1997, 82 (04) : 507 - 508
  • [9] METHOTREXATE AND ASPARAGINASE COMBINATION CHEMOTHERAPY IN REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD
    LOBEL, JS
    OBRIEN, RT
    MCINTOSH, S
    ASPNES, GT
    CAPIZZI, RL
    CANCER, 1979, 43 (03) : 1089 - 1094
  • [10] COST-EFFECTIVENESS ANALYSIS OF CLOFARABINE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    Dorantes, M. E. A.
    VALUE IN HEALTH, 2009, 12 (07) : A496 - A496
12345